These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 6734708)

  • 1. Individualizing theophylline dosage: evaluation of a single-point maintenance dose prediction method.
    Wilkens JH; Neuenkirchen H; Sybrecht GW; Oellerich M
    Eur J Clin Pharmacol; 1984; 26(4):491-8. PubMed ID: 6734708
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical utility of the single point method for theophylline maintenance dose prediction.
    Abad J; Pastor A; Prieto L; Palop J; Jiménez Torres V; Castro J
    Allergol Immunopathol (Madr); 1987; 15(6):355-9. PubMed ID: 3445876
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Accuracy of 11 methods for predicting theophylline dose.
    Rodvold KA; Paloucek FP; Zell M
    Clin Pharm; 1986 May; 5(5):403-8. PubMed ID: 3720210
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the Chiou method for determining theophylline dosages.
    Johnson MH; Burkle WS
    Clin Pharm; 1984; 3(2):174-8. PubMed ID: 6723223
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of a novel Bayesian method for individualizing theophylline dosage.
    Stein U; Oellerich M; Sybrecht GW; Schneider B
    J Clin Chem Clin Biochem; 1988 Jun; 26(6):405-14. PubMed ID: 3411295
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Theophylline in serum and in bronchoalveolar lavage (BAL) in atopic bronchial asthma and chronic bronchitis.
    Plusa T; Józefczak E; Raczka A
    Allergol Immunopathol (Madr); 1989; 17(1):29-32. PubMed ID: 2750638
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Large theophylline requirements due to high theophylline clearance: verification by the antipyrine test.
    Blyden GT; LeDuc BW; Greenblatt DJ
    Pharmacology; 1986; 32(4):226-31. PubMed ID: 3714804
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prediction of optimum oral theophylline dose in patients with obstructive airways disease.
    Taylor DR; Kinney CD; McDevitt DG
    Br J Clin Pharmacol; 1983 Jun; 15(6):689-94. PubMed ID: 6871068
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circadian changes in the absorption and elimination of theophylline in patients with bronchial obstruction.
    Uematsu T; Follath F; Vozeh S
    Eur J Clin Pharmacol; 1986; 30(3):309-12. PubMed ID: 3732366
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A single oral dose method for predicting steady state theophylline concentrations in clinical practice.
    Mann JS; Fitzpatrick RW; Jones PW; Prowse K; Mucklow JC; Cole RB
    Respir Med; 1990 Nov; 84(6):479-84. PubMed ID: 2274687
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dose-dependent kinetics of theophylline in adults with pulmonary diseases.
    Massey KL; Gotz VP; Russell WL
    Ther Drug Monit; 1984; 6(3):284-9. PubMed ID: 6506135
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Individualization of theophylline dosage in adults with bronchial asthma.
    Otero MJ; Barrueco M; Mariño EL; Gomez F; Dominguez-Gil A
    Drug Intell Clin Pharm; 1986 Sep; 20(9):704-7. PubMed ID: 3757785
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The theophylline test. Indications for the effective daily dosage (author's transl)].
    Blaive B; Bugnas B; Lapalus P; Lemoigne F
    Rev Fr Mal Respir; 1982; 10(3):205-12. PubMed ID: 7111830
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Theophylline in childhood asthma. Pharmacokinetic and clinical study (author's transl)].
    Bellon G; Plasse JC; Satta S; Barbier Y; Gilly R
    Rev Fr Mal Respir; 1981; 9(2):113-21. PubMed ID: 7255850
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Individualized aminophylline therapy in patients with obstructive airway disease: oral dosage prediction from an intravenous test dose.
    Horai Y; Ishizaki T; Sasaki T; Watanabe M; Kabe J
    Eur J Clin Pharmacol; 1982; 23(2):111-21. PubMed ID: 7140800
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship of formulation and dosing interval to fluctuation of serum theophylline concentration in children with chronic asthma.
    Weinberger M; Hendeles L; Wong L
    J Pediatr; 1981 Jul; 99(1):145-52. PubMed ID: 7252652
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Theophylline disposition in acutely ill hospitalized patients. The effect of smoking, heart failure, severe airway obstruction, and pneumonia.
    Powell JR; Vozeh S; Hopewell P; Costello J; Sheiner LB; Riegelman S
    Am Rev Respir Dis; 1978 Aug; 118(2):229-38. PubMed ID: 697173
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A clinical and pharmacokinetic basis for the selection and use of slow release theophylline products.
    Hendeles L; Iafrate RP; Weinberger M
    Clin Pharmacokinet; 1984; 9(2):95-135. PubMed ID: 6370542
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prediction of maintenance oral theophylline dosage using single oral doses in patients with obstructive airways disease.
    Taylor DR; Kinney CD; McDevitt DG
    Br J Clin Pharmacol; 1983 Nov; 16(5):511-6. PubMed ID: 6639837
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Theophylline for chronic asthma: rationale for treatment, product selection, and dosage schedule.
    Weinberger M; Hendeles L
    Pediatr Pharmacol (New York); 1983; 3(3-4):273-85. PubMed ID: 6429620
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.